{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:19:10Z","timestamp":1785806350569,"version":"3.56.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jiph.2023.12.005","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T02:48:25Z","timestamp":1702349305000},"page":"245-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Real-world effectiveness of the inactivated COVID-19 vaccines against variant of concerns: meta-analysis"],"prefix":"10.1016","volume":"17","author":[{"given":"Muhammad Usman","family":"Sarwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathimathuz Zehra","family":"Waasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram Ahmed","family":"Aloqbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher","family":"Alandiyjany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem Mohammed","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna Abdulrahman","family":"Hafiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghalia","family":"Shamlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1508-5161","authenticated-orcid":false,"given":"Mohammed","family":"Albreiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7798","key":"10.1016\/j.jiph.2023.12.005_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jiph.2023.12.005_bib2","unstructured":"Medicine JHUo. COVID-19 Dashboard at Johns Hopkins University. 2020 [cited 2023 28 February]. Available from: https:\/\/coronavirus.jhu.edu\/map.html."},{"key":"10.1016\/j.jiph.2023.12.005_bib3","article-title":"Features, evaluation, and treatment of coronavirus (COVID-19)","author":"Cascella","year":"2023","journal-title":"StatPearls"},{"issue":"10","key":"10.1016\/j.jiph.2023.12.005_bib4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41577-020-00434-6","article-title":"Immunological considerations for COVID-19 vaccine strategies","volume":"20","author":"Jeyanathan","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jiph.2023.12.005_bib5","unstructured":"Organization W.H. Global COVID-19 Vaccination Strategy in a Changing World: July 2022 update. World Health Organization https:\/\/www who int\/publications\/m\/item\/global-covid-19-vaccination-strategy-in-achanging-world--july-2022-update. 2022."},{"issue":"2","key":"10.1016\/j.jiph.2023.12.005_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/bioengineering9020072","article-title":"COVID-19 vaccines: an overview of different platforms","volume":"9","author":"Kudlay","year":"2022","journal-title":"Bioengineering"},{"key":"10.1016\/j.jiph.2023.12.005_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108162","article-title":"A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines","volume":"100","author":"Ghasemiyeh","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"13","key":"10.1016\/j.jiph.2023.12.005_bib9","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.vaccine.2022.02.039","article-title":"Impact of the Sinopharm\u2019s BBIBP-CorV vaccine in preventing hospital admissions and death in infected vaccinees: Results from a retrospective study in the emirate of Abu Dhabi, United Arab Emirates (UAE)","volume":"40","author":"AlHosani","year":"2022","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.jiph.2023.12.005_bib10","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S1473-3099(22)00345-0","article-title":"Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study","volume":"22","author":"McMenamin","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2023.12.005_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-33169-0","article-title":"Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil","volume":"13","author":"Ranzani","year":"2022","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.jiph.2023.12.005_bib12","doi-asserted-by":"crossref","first-page":"e798","DOI":"10.1016\/S2214-109X(22)00112-7","article-title":"Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study","volume":"10","author":"Jara","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"48","key":"10.1016\/j.jiph.2023.12.005_bib13","doi-asserted-by":"crossref","first-page":"7286","DOI":"10.1016\/j.vaccine.2018.04.016","article-title":"A framework for research on vaccine effectiveness","volume":"36","author":"Crowcroft","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jiph.2023.12.005_bib14","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s10787-021-00839-2","article-title":"Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies","volume":"29","author":"Kow","year":"2021","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.jiph.2023.12.005_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10787-021-00915-7","article-title":"The effectiveness of BNT162b2 mRNA vaccine against COVID-19 caused by Delta variant of SARS-CoV-2: a systematic review and meta-analysis","volume":"30","author":"Kow","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"4","key":"10.1016\/j.jiph.2023.12.005_bib16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa2107058","article-title":"Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines","volume":"385","author":"Thompson","year":"2021","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.jiph.2023.12.005_bib17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.15585\/mmwr.mm7013e3","article-title":"Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers\u2014eight US locations, December 2020\u2013March 2021","volume":"70","author":"Thompson","year":"2021","journal-title":"Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.jiph.2023.12.005_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-022-02397-y","article-title":"Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis","volume":"20","author":"Zeng","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.jiph.2023.12.005_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/14760584.2023.2156861","article-title":"Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic review","author":"Sandoval","year":"2023","journal-title":"Expert Rev Vaccin"},{"issue":"18","key":"10.1016\/j.jiph.2023.12.005_bib20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.15585\/mmwr.mm7118a4","article-title":"Effectiveness of a COVID-19 additional primary or booster vaccine dose in preventing SARS-CoV-2 infection among nursing home residents during widespread circulation of the Omicron variant\u2014United States, February 14\u2013March 27, 2022","volume":"71","author":"Prasad","year":"2022","journal-title":"Morb Mortal Wkly Rep"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034123004422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034123004422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:19:03Z","timestamp":1761751143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034123004422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1876034123004422"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2023.12.005","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world effectiveness of the inactivated COVID-19 vaccines against variant of concerns: meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2023.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}